Backed by ARCH Venture Partners, F-Prime Capital and Mubadala Capital, the new company will develop a pipeline of ...

About a year ago, Tenvie President and Chief Scientific Officer Tony Estrada approached Denali CEO Ryan Watts and others in ...

CI Financial ( TSX: CIX:CA) ( OTCPK:CIXXF) received an interim order from the Ontario Superior Court of Justice that ...

Light Horse Therapeutics Inc., a developer of first-in-class small molecule therapeutics, today announced a $62 million Series A financing. The financing was led by founding investor Versant Ventures ...

Tenvie Therapeutics has unveiled with $200 million and the goal of transforming the neurological treatment landscape, nabbing ...

CI Financial receives an interim court order concerning the transaction under which CI shares will be acquired by an affiliate of Mubadala Capital.

“Tenvie was purpose-built to apply deep biological and chemical insights to address critical disease pathways,” said Paul L. Berns, Managing Director at ARCH Venture Partners and Executive Chair of ...

Tenvie Therapeutics is making hay from an R&D shift at Denali Therapeutics, acquiring several of its neuroscience drug ...

The latest announcement is out from CI Financial ( (TSE:CIX) ).

Howden is being advised on the raise by Morgan Stanley.

State-owned investors, notably sovereign wealth funds (SWFs) and public pension funds (PPFs), are significantly increasing ...

Abu Dhabi’s Mubadala Investment Co. was the world’s most active sovereign wealth fund last year as it ramped up deal-making ...